Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Exclusion Criteria

• •Participant has experienced \>=Grade 2 CIT other than during the current chemotherapy treatment regimen within 6 months of Screening;
• •Participant has any history of hematologic malignancies, including leukemia, myeloma, myeloproliferative disease, lymphoma, or myelodysplastic diseases;
• •Participant has received \>2 previous lines of chemotherapy or is receiving whole brain radiation during the study treatment period;
• •Participant has a known medical history of genetic prothrombotic syndromes
• •Participant has a history of arterial or venous thrombosis within 3 months of screening;
• •Use of vitamin K antagonists;
• •Participant has previously received a thrombopoietin receptor agonist or recombinant human thrombopoietin for the treatment of CIT within 3 months of screening